Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Josephine M. Cardarelli is active.

Publication


Featured researches published by Josephine M. Cardarelli.


Archive | 2006

Altered Antibody FC Regions and Uses Thereof

Genevieve Hansen; Gerald Neslund; Amelia Nancy Black; Josephine M. Cardarelli; Srinivasan Mohan; David John King


Archive | 2008

Anti-b7h4 monoclonal antibody-drug conjugate and methods of use

Jonathan A. Terrett; Josephine M. Cardarelli; Chetana Rao-Naik; Bingliang Chen; David J. King


Archive | 2006

Human monoclonal antibody to pd-1 (programmed death 1) and method for treating cancer using the same anti-pd-1 antibody alone or in combination with other immunotherapy

Josephine M. Cardarelli; Bing Chen; Alan J. Korman; Mark J. Selby; Mohan Srinivasan; Changyu Wang; チャンギュ ウォン; ジョセフィーヌ エム カルダレッリ; アラン ジェイ コーマン; モハン スリニバサン; マーク ジェイ セルビー; ビング チェン


Archive | 2012

Treatment of hematologic malignancies with an anti-cxcr4 antibody

Michelle Kuhne; Chin Pan; Josephine M. Cardarelli


Archive | 2008

Conjugates of anti-rg-1 antibodies

David J. King; Jonathan A. Terrett; Sanjeev Gangwar; Josephine M. Cardarelli; Chetana Rao-Naik; Chin Pan


Archive | 2013

Bispecific antibodies and methods of using the same

Brenda L. Stevens; Alison Witte; Mark W. Rixon; Josephine M. Cardarelli; Thomas D. Kempe; Scott R. Presnell; Mohan Srinivasan; Susan C. Wong; Guodong Chen; Hui Wei; Stanley R. Krystek; Lumelle A. Schneeweis; Paul O. Sheppard; Indrani Chakraborty; Mian Gao; Steven Sheriff; Noah Ditto; Nels B. Hamacher; Thomas E. Edwards; Kateri Atkins; Tracy Arakaki


Journal of Clinical Oncology | 2017

A phase 1 multicenter open-label dose-escalation study of BMS-936561 (MDX-1203) in clear cell renal cell carcinoma (ccRCC) and B-cell non Hodgkin lymphoma (B-NHL).

Taofeek K. Owonikoko; Arif Hussain; Walter M. Stadler; David C. Smith; Mario Sznol; Ana M. Molina; Parul Gulati; Aadhar Shah; Christoph Matthias Ahlers; Josephine M. Cardarelli; Lewis J. Cohen


Archive | 2006

Irta-1 antibodies and their uses

Robert F. Graziano; David John King; Thomas D. Kempe; Mohan Srinivasan; Josephine M. Cardarelli; Morgan Truitt; Jie Liu


Archive | 2013

Bispecific antibodies to IL-23 and IL-17A/F

Brenda L. Stevens; Alison Witte; Mark W. Rixon; Josephine M. Cardarelli; Thomas D. Kempe; Scott R. Presnell; Mohan Srinivasan; Susan C. Wong; Guodong Chen; Hui Wei; Stanley R. Krystek; Lumelle A. Schneeweis; Paul O. Sheppard; Indrani Chakraborty


Journal of Clinical Oncology | 2018

Phase 1b/2 study of nivolumab in combination with an anti–IL-8 monoclonal antibody, BMS-986253, in a biomarker-enriched population of patients with advanced cancer.

Ignacio Melero Bermejo; Elizabeth M. Jaffee; Diwakar Davar; Josephine M. Cardarelli; Daphne Williams; Penny Phillips; Michael Carleton; Ming Zhou; Olivier De Henau; Manish Monga; Charles G. Drake

Collaboration


Dive into the Josephine M. Cardarelli's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Chin Pan

Bristol-Myers Squibb

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge